Literature DB >> 6718940

The impact of different antimicrobial agents on the normal gastrointestinal microflora of humans.

C E Nord, A Heimdahl, L Kager, A S Malmborg.   

Abstract

In the present study the impact on the gastrointestinal microflora of peroral administration of penicillin, bacampicillin, clindamycin, erythromycin, doxycycline, and tinidazole was investigated. The effects on the colonic flora of parenteral administration of ampicillin plus sulbactam, cefoxitin, clindamycin, and tinidazole also were studied. Pronounced changes were observed in the oropharyngeal and colonic microflora in patients receiving clindamycin, erythromycin, and tinidazole (intravenous), whereas moderate changes were seen in those patients receiving doxycycline, cefoxitin, and ampicillin plus sulbactam. Penicillin, bacampicillin, and tinidazole (peroral) produced only minor changes. In most patients with an altered microflora, colonization with new bacterial strains was found.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6718940     DOI: 10.1093/clinids/6.supplement_1.s270

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  11 in total

1.  Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.

Authors:  C J Donskey; T K Chowdhry; M T Hecker; C K Hoyen; J A Hanrahan; A M Hujer; R A Hutton-Thomas; C C Whalen; R A Bonomo; L B Rice
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

Review 2.  Studies on the ecological impact of antibiotics.

Authors:  C E Nord
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-07       Impact factor: 3.267

3.  Prophylaxis of infection by selective decontamination in mechanically ventilated patients. A preliminary report.

Authors:  S J Aerdts; R van Dalen; H A Clasener; E J Vollaard
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 4.  Requirements for the documentation of pharmacokinetic properties of antimicrobial agents.

Authors:  T Bergan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-07       Impact factor: 3.267

5.  Inhibition of Bacteroidetes and Firmicutes by select phytochemicals.

Authors:  Jourdan E Lakes; Christopher I Richards; Michael D Flythe
Journal:  Anaerobe       Date:  2019-12-24       Impact factor: 3.331

Review 6.  A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.

Authors:  C Edlund; C E Nord
Journal:  Infection       Date:  1988       Impact factor: 3.553

7.  Impact of imipenem/cilastatin therapy on faecal flora.

Authors:  C E Nord; L Kager; A Philipson; G Stiernstedt
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

Review 8.  Piperacillin-tazobactam as alternative to carbapenems for ICU patients.

Authors:  Benoit Pilmis; Vincent Jullien; Alexis Tabah; Jean-Ralph Zahar; Christian Brun-Buisson
Journal:  Ann Intensive Care       Date:  2017-11-10       Impact factor: 6.925

Review 9.  Rethinking antimicrobial stewardship paradigms in the context of the gut microbiome.

Authors:  Farah Shahi; Kelly Redeker; James Chong
Journal:  JAC Antimicrob Resist       Date:  2019-05-21

10.  Effects of treatment with antimicrobial agents on the human colonic microflora.

Authors:  Fatemeh Rafii; John B Sutherland; Carl E Cerniglia
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.